Research-grade compound. Laboratory use only. Not intended for human or animal use, ingestion, or injection. No medical claims are made or implied.
Semax + Selank Blend 20mg
Free shipping on orders over €200
- If a product doesn't match the specification on its published COA, contact us with your batch number: we investigate against the lot's report and replace any product that fails it, at no cost to you.
- Contact us within 48 hours of delivery with photos of the outer box, inner packing, and any affected vials with labels legible. Confirmed transit damage is replaced at no cost to you.
3–7 days most of the EU · 10–14 Nordics/Baltics
Standard EU from €4.99 (RO) · core EU GLS €17.99 · Nordics/Baltics €12.99–€15.99 · Dispatched within 1–2 business days · Free shipping over €200.00 · no customs paperwork (EU) · via EU carrier network
€200.00 away from free shipping over €200.00. Under that, standard EU shipping is €17.99 (GLS, most of the EU).
How Paysera and SEPA work
- Pay: send a manual SEPA transfer using the IBAN we email you, or, where checkout offers it for your address, approve a SEPA transfer in your own bank via Paysera's hosted page.
- We confirm — Paysera notifies us instantly, or we match a manual transfer when it arrives (usually 1 business day).
- We dispatch — confirmed orders typically ship within 1–2 business days.
Card payments are not currently offered. There is no card processor on this checkout.
Research-grade Semax + Selank Blend. A multi-peptide blend has no single purity figure; selected lots independently tested. Lyophilized powder in sealed glass vial. For laboratory research use only. Not for human consumption.
| Quantity | Price Each | Total | Savings |
|---|---|---|---|
| 1 unit | €49.99 | €49.99 | -- |
| 3+ | €47.49 | €142.47 | 5% off |
| 5+Most Popular | €44.99 | €224.95 | 10% off |
| 10+ | €42.49 | €424.92 | 15% off |
Important Notice
This product is intended for laboratory and research use only. Not for human or veterinary use. By purchasing, you confirm this product will be used exclusively for in-vitro research purposes.
Due to legal and regulatory requirements, this product cannot be shipped to: Italy.
Reconstitution Required
This peptide ships lyophilized (dry powder) and requires bacteriostatic water to reconstitute before use. BAC water is sold separately.
When This Product May Not Suit Your Research
- ⚠If your research requires GMP-grade material for clinical applications — research-grade peptides are not intended for clinical use.
- ⚠If your lab lacks proper cold storage (-20°C freezer) — this peptide's stability may be compromised at higher temperatures.
- ⚠If your study protocol requires FDA-approved reference standards — contact USP or a certified reference material provider.
Published laboratory reports are available for selected lots. Check each report for its result and stated method. For research purposes only.
View report #212142 on janoshik.com →
Dispatched within 1–2 business days, shipping from €4.99 in Romania, from €12.99 across the rest of Europe
About Semax + Selank Blend 20mg
Semax + Selank Blend combines two Russian-developed nootropic peptides with different but complementary mechanisms in a single vial (10mg each, 20mg total). Both were developed by the Institute of Molecular Genetics of the Russian Academy of Sciences and have an unusually long research history in Russia and Eastern Europe -- a distinction that provides some pharmacology data, even if that literature predates modern trial standards.
Semax is a synthetic heptapeptide derived from the ACTH(4-7) sequence (methionine-glutamate-histidine-phenylalanine) with a proline-glycine-proline extension that increases its stability and bioactivity. In research models it is studied for its role in BDNF and NGF pathways -- upregulating brain-derived and nerve growth factors. Research effects include neuroprotection, acetylcholinergic and neuropeptidergic receptor binding in memory consolidation models, and attention-related parameters. Semax has been studied in models of ischemic injury, which provides some translational context, though the evidence base is not equivalent to Western Phase III trial standards.
Selank is derived from tuftsin, an endogenous immunoregulatory peptide. In research models it is studied for its interaction with the GABA system, including a GABA-B receptor component. Selank has also been studied for immunomodulatory activity, including stress-induced immune suppression in animal models.
The combination addresses both acetylcholinergic and neuropeptidergic receptor binding (Semax) and GABA-system and immunomodulatory signalling (Selank) -- complementary rather than redundant mechanisms in the context of cognitive performance research.
Specifications
| Parameter | Value |
|---|---|
| Component 1 | Semax 10mg (ACTH(4-7) derivative) |
| Component 2 | Selank 10mg (Tuftsin analogue) |
| Total per Vial | 20mg combined |
| Purity | No single figure (multi-peptide blend) |
| Format | Lyophilized powder, single-use vial |
| Storage | -20°C before reconstitution; 2-8°C after |
Storage
Store at -20°C before reconstitution. Refrigerate at 2-8°C after reconstitution. No blend-specific use window is published once mixed. Both peptides are stable under proper conditions but should be protected from light and heat.
What is the mechanism of Semax as a nootropic?
Semax is derived from the ACTH(4-7) sequence -- the minimal active fragment of adrenocorticotropic hormone -- modified for stability. Its primary documented mechanisms in research models involve upregulation of BDNF and NGF, neurotrophins that support neuronal survival, plasticity, and function. In rodent models it enhances learning, memory consolidation, and attention-related parameters. It also has documented neuroprotective effects in ischemia models, which is an active area of preclinical research.
How is Selank studied in research models?
Selank is studied in rodent models for its interaction with the GABA system, including GABA-B components, and for its immunomodulatory activity.
In what form is this blend supplied?
Semax and Selank are supplied together as a lyophilized blend in a single vial, for reconstitution in laboratory research only.
Semax + Selank Blend is supplied for laboratory research use only. Not approved for human use. Handle in compliance with institutional biosafety guidelines.
Specification Summary
About Semax + Selank Blend 20mg
Semax + Selank Blend combines two Russian-developed nootropic peptides with different but complementary mechanisms in a single vial (10mg each, 20mg total). Both were developed by the Institute of Molecular Genetics of the Russian Academy of Sciences and have an unusually long research history in Russia and Eastern Europe -- a distinction that provides some pharmacology data, even if that literature predates modern trial standards.
Semax is a synthetic heptapeptide derived from the ACTH(4-7) sequence (methionine-glutamate-histidine-phenylalanine) with a proline-glycine-proline extension that increases its stability and bioactivity. In research models it is studied for its role in BDNF and NGF pathways -- upregulating brain-derived and nerve growth factors. Research effects include neuroprotection, acetylcholinergic and neuropeptidergic receptor binding in memory consolidation models, and attention-related parameters. Semax has been studied in models of ischemic injury, which provides some translational context, though the evidence base is not equivalent to Western Phase III trial standards.
Selank is derived from tuftsin, an endogenous immunoregulatory peptide. In research models it is studied for its interaction with the GABA system, including a GABA-B receptor component. Selank has also been studied for immunomodulatory activity, including stress-induced immune suppression in animal models.
The combination addresses both acetylcholinergic and neuropeptidergic receptor binding (Semax) and GABA-system and immunomodulatory signalling (Selank) -- complementary rather than redundant mechanisms in the context of cognitive performance research.
Specifications
| Parameter | Value |
|---|---|
| Component 1 | Semax 10mg (ACTH(4-7) derivative) |
| Component 2 | Selank 10mg (Tuftsin analogue) |
| Total per Vial | 20mg combined |
| Purity | No single figure (multi-peptide blend) |
| Format | Lyophilized powder, single-use vial |
| Storage | -20°C before reconstitution; 2-8°C after |
Storage
Store at -20°C before reconstitution. Refrigerate at 2-8°C after reconstitution. No blend-specific use window is published once mixed. Both peptides are stable under proper conditions but should be protected from light and heat.
What is the mechanism of Semax as a nootropic?
Semax is derived from the ACTH(4-7) sequence -- the minimal active fragment of adrenocorticotropic hormone -- modified for stability. Its primary documented mechanisms in research models involve upregulation of BDNF and NGF, neurotrophins that support neuronal survival, plasticity, and function. In rodent models it enhances learning, memory consolidation, and attention-related parameters. It also has documented neuroprotective effects in ischemia models, which is an active area of preclinical research.
How is Selank studied in research models?
Selank is studied in rodent models for its interaction with the GABA system, including GABA-B components, and for its immunomodulatory activity.
In what form is this blend supplied?
Semax and Selank are supplied together as a lyophilized blend in a single vial, for reconstitution in laboratory research only.
Semax + Selank Blend is supplied for laboratory research use only. Not approved for human use. Handle in compliance with institutional biosafety guidelines.
Researcher Confidence
Why researchers choose CertaPeptides
Who actually tests this?
Selected lots are independently verified by Janoshik Analytical (Czech Republic) and published on the Janoshik public portal. Other lots ship with the supplier's batch specification. See /coa for the published wall.
View COAs →What if I get the wrong batch?
Every vial label carries a code. Look it up on our Verify page: it shows what CertaPeptides publishes for that code and, for a withdrawn lot, that the lot was withdrawn and why. If yours is withdrawn, or if the code on your label finds nothing, email us that code.
View COAs →Where does it ship from?
Romania (EU). We are CERTALAB SRL, CUI 54169956, VAT-registered. Sameday for Romania, GLS for most EU destinations, TCE Worldwide for the remaining cross-border EU and non-EU markets (UK, Switzerland). Delivery 1–15 business days depending on destination — exact window shown at checkout.
Shipping details →What if there's a problem?
You have a 14-day withdrawal right under OUG 34/2014 (Romanian/EU consumer law), with escalation to ANPC and alternative dispute resolution (SAL) available. Contact us at support@certapeptides.com.
Returns policy →Product Information
This product is intended for scientific research and development purposes only. It is a chemical substance that shall not be used as a drug, medicine, active substance, or ingredient in any product intended for human or animal consumption. Researchers must handle this compound in accordance with their institutional biosafety guidelines. Use only in properly equipped laboratory settings with appropriate personal protective equipment.
